430 related articles for article (PubMed ID: 12869020)
1. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.
Sprong T; Brandtzaeg P; Fung M; Pharo AM; Høiby EA; Michaelsen TE; Aase A; van der Meer JW; van Deuren M; Mollnes TE
Blood; 2003 Nov; 102(10):3702-10. PubMed ID: 12881318
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.
Thomas TC; Rollins SA; Rother RP; Giannoni MA; Hartman SL; Elliott EA; Nye SH; Matis LA; Squinto SP; Evans MJ
Mol Immunol; 1996 Dec; 33(17-18):1389-401. PubMed ID: 9171898
[TBL] [Abstract][Full Text] [Related]
4. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
[TBL] [Abstract][Full Text] [Related]
5. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
[TBL] [Abstract][Full Text] [Related]
6. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species.
Zelek WM; Morgan BP
Front Immunol; 2020; 11():612402. PubMed ID: 33424866
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the C5-C5a receptor axis.
Woodruff TM; Nandakumar KS; Tedesco F
Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
[TBL] [Abstract][Full Text] [Related]
9. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
[TBL] [Abstract][Full Text] [Related]
10. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.
Larrick JW; Wang J; Fendly BM; Chenoweth DE; Kunkel SL; Deinhart T
Infect Immun; 1987 Aug; 55(8):1867-72. PubMed ID: 2440808
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.
Evans MJ; Rollins SA; Wolff DW; Rother RP; Norin AJ; Therrien DM; Grijalva GA; Mueller JP; Nye SH; Squinto SP
Mol Immunol; 1995 Nov; 32(16):1183-95. PubMed ID: 8559143
[TBL] [Abstract][Full Text] [Related]
12. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
[TBL] [Abstract][Full Text] [Related]
13. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
[TBL] [Abstract][Full Text] [Related]
14. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.
Harboe M; Ulvund G; Vien L; Fung M; Mollnes TE
Clin Exp Immunol; 2004 Dec; 138(3):439-46. PubMed ID: 15544620
[TBL] [Abstract][Full Text] [Related]
15. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
16. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
[TBL] [Abstract][Full Text] [Related]
17. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
18. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
Elsner J; Oppermann M; Kapp A
Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
20. Generation of complement molecular complex C5b-9 (C5b-9) in response to poly-traumatic hemorrhagic shock and evaluation of C5 cleavage inhibitors in non-human primates.
Paredes RM; Reyna S; Vernon P; Tadaki DK; Dallelucca JJ; Sheppard F
Int Immunopharmacol; 2018 Jan; 54():221-225. PubMed ID: 29156357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]